Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 81687

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : April | Volume : 17 | Issue : 4 | Page : DC10 - DC14 Full Version

Microbiological Profile of Osteomyelitis and Antibiotic Resistance Pattern of Bacterial Isolates with Special Reference to MDR Strains at a Tertiary Care Hospital, Kanpur, Uttar Pradesh, India


Published: April 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/62082.17785
Rohan Nigam, Suneet Kumar Yadav, R Sujatha, Deepak Sameer Bind, Nashra Afaq

1. Microbiologist, Department of Microbiology, Regency Hospital, Kanpur, Uttar Pradesh, India. 2. Assistant Professor, Department of Microbiology, Rama Medical College, Kanpur, Uttar Pradesh, India. 3. Professor, Department of Microbiology, Rama Medical College, Kanpur, Uttar Pradesh, India. 4. Tutor, Department of Microbiology, Rama Medical College, Kanpur, Uttar Pradesh, India. 5. Research Associate, Department of Microbiology, Rama Medical College, Kanpur, Uttar Pradesh, India.

Correspondence Address :
Dr. R Sujatha,
Professor, Department of Microbiology, Rama Medical College, Kanpur-209217, Uttar Pradesh, India.
E-mail: drsujatha152@gmail.com

Abstract

Introduction: Osteomyelitis is an inflammatory process that affects bone due to the contiguous infection, direct inoculation, or haematogenous spread of microorganisms. It is an infectious disease that is difficult to diagnose and treatment is complex because of its heterogeneity, pathophysiology, clinical presentation and management.

Aim: To determine microbiological profile osteomyelitis and antibiotic resistance pattern of bacterial isolates with special reference to Multidrug Resistance (MDR) strains.

Materials and Methods: A cross-sectional study was conducted in the Department of Microbiology and Department of Orthopaedics, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India. A total of 100 samples from osteomyelitis cases were aerobically cultured and isolates from culture positives were identified by standard procedures. Antimicrobial Susceptibility Testing (AST) was done following Clinical and Laboratory Standards Institute (CLSI) guidelines. Staphylococcal isolates were screened for methicillin resistance and Gram-negative bacilli were screened for MDR production. The data was entered in Microsoft excel.

Results: Out of 100 samples, 76% were culture positive and 24% were culture negative. Males were more affected than females. Staphylococcal spp. (47.4%) was predominant, E. coli (14.4%) and Klebsiella spp. (11.8%), Pseudomonas spp. (9.2%), Proteus spp. (5.2%), Coagulase-Negative Staphylococci (CoNS) (4%). Among the MDR strains, Methicillin-resistant Staphylococcus aureus (MRSA) was 44.4%. All the MDR Staphylococcal isolates were 100% sensitive for linezolid. Among the MDR Gram-negative bacilli were Extended Spectrum Beta Lactamases (ESBL) (50%), AmpC (17.6%) and Metallo-beta-lactamases (MBL) (14.7%) and they were 100% sensitive for polymixin B and colistin.

Conclusion: The microbiological profile of osteomyelitis in the present study showed high prevalence of MRSA 44% as the commonest agent, sensitive only to linezolid. E. coli ESBL (50%) and MBL 14.7% were sensitive only to colistin and polymixin B, therefore proper infection control practices and antibiotic policy has to be followed to reduce the incidence of MDR strains.

Keywords

Extended spectrum beta lactamase, Metallo-beta-lactamases, Methicillin-resistant Staphylococcus aureus, Multidrug resistance

The word “osteomyelitis” is derived from the ancient Greek words osteo (meaning bone) and muelinos (meaning marrow) and simply means an infection of medullar portion of the bone (1). The term osteomyelitis was first used by the French surgeon Edouard Chassaignac in 1852, who defined the disease as an inflammatory process accompanied by bone destruction and is caused by an infecting microorganism (2). Osteomyelitis is an inflammatory process that affects bone due to the contiguous infection, direct inoculation, or haematogenous spread of microorganisms (3). Current interest in this condition has increased due to recent changes in the epidemiology, pathogenesis, diagnosis, treatment and prognosis of the disease (4),(5).

However, it is not a single entity; this disease is differentiated according to the aetiology, pathogenesis and degree of bone involvement, as well as age and the immune condition of the patient (6). The reported incidence has increased due to co-morbidities such as diabetes mellitus, peripheral vascular disease, trauma and surgery (7). After an open fracture, the incidence of osteomyelitis can range from 2-16% depending on the type of injury and the treatment administered (8). It can involve different structures such as the bone marrow, cortex, periosteum and parts of the surrounding soft tissues, or remain localised (9). Osteomyelitis mostly affects the growing ends of long bones and it is more common in the lower extremity at metaphysis of femur and proximal end of tibia (10).

Various microorganisms can reach to bone through blood and cause inflammation in bone tissue; rarely soft tissue infection may lead to bone damage. Microorganism reach to the metaphysis of bone through blood flow from skin wound, upper respiratory tract infection, periodontitis and any other infectious region. Bone metaphysic is a region full of blood vessels and slow blood stream which can spread the infection. Direct trauma to bone may cause osteomyelitis (11).

The two most widely used classification systems for osteomyelitis are by Waldvogel FA et al., and Cierny G et al., [12,13]. Under the Waldvogel system, osteomyelitis is first described according to duration, either acute or chronic. Second, the disease is classified according to source of infection, as haematogenous when it originates from a bacteremia or as contiguous focus when it originates from an infection in a nearby tissue. A final category of the classification is vascular insufficiency (14). The Cierny-Mader osteomyelitis classification combines both anatomic factors (medullar, superficial, localised, or diffuse osteomyelitis) and physiological classes (healthy host, systemic and/or local compromise, and treatment worse than the disease) (15),(16). This classification applies best to long and large bones and it is not very useful for the digits, small bones, or the skull (17),(18),(19).

Diagnosis of this condition mainly depends on strong clinical suspicion in non healing ulcer especially in diabetic patient, radiological findings of translucency of bone with patchy sclerosis and adjacent periosteal bone reaction. Magnetic Resonance Imaging (MRI) and blood culture along with deeper bone biopsy or culture and pus culture are mainstay in management protocol of these patients (20). The bacteria most commonly causing chronic osteomyelitis are Staphylococcus aureus, Coagulase negative Staphylococcus, Pseudomonas spp., E. coli, Proteus spp., Klebsiella spp., Enterococcus spp., Enterobacter spp. and anaerobes like Peptostreptococcus spp., Bacteroides spp., Clostridium spp. Rarely Salmonella spp. and Actinomycetes (21), Staphylococcus aureus constitutes 50-75% cases of chronic osteomyelitis. In most of the cases infection is monomicrobial, infection with multiple organisms are usually seen in diabetes mellitus patients with ulcer in foot (22).

Osteomyelitis is an ongoing problem due to emergence of Multidrug Resistance (MDR) strains among bacterial pathogens. Beta lactamases are the most evolving mechanism of antibiotic resistance among the family Enterobacteriaceae due to the selective pressure imposed by inappropriate use of third generation cephalosporins, most often encountered in Intensive Care Unit (ICU) settings (23). Extended Spectrum Beta Lactamases (ESBL) and AmpC enzymes are the most common known beta lactamases. Carbapenems represented a great advance for the treatment of serious bacterial infections caused by beta lactam resistant bacteria (24). But extensive and unnecessary use of the carbapenems facilitated the emergence of carbapenem resistant bacteria which produced carbapenem hydrolysing enzyme Metallo Beta Lactamase (MBL), so called because they contain metal ion that works as a co-factor for enzymatic activity (25). Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent worldwide and are an important cause of nosocomial infection, resulting in increased morbidity and mortality in the hospital settings worldwide (26).

The study was therefore undertaken to determine the microbiological profile of these cases of osteomyelitis and also to ascertain the antibiotic resistance pattern of these isolates and to find out the MDR strains at a tertiary care centre. It will go a long way in helping the clinician in deciding upon the treatment regime for these patients. The data generated by these studies will also help in formulating hospital antibiotic policies.

Material and Methods

This cross-sectional observational study was conducted in the Department of Microbiology and Department of Orthopaedics, Rama Medical College Hospital and Research Centre, Kanpur, Uttar Pradesh, India, from January to December 2020. Samples from outpatients and inpatients admitted to the orthopaedic ward suspected to have osteomyelitis was collected after obtaining consent from patients. Ethical clearance was taken from the Institutional Ethical Committee (IEC) reference number (MEC/Reg.N./ECR/872/Inst/2016).

Sample size calculation: n=4PQ/L2 Where, P=Prevalence, Q=100-p, L=Allowable error, If the allowable error is 10% SS (n)=4×57×43/100

Sample size, n=9804/100=98.04

So, in order to cover up the lost to follow-up, drop-out rate and non response rate the sample size taken in present research study was 100 (27).

Inclusion criteria: Clinically diagnosed cases of osteomyelitis belonging to all age group and both sexes were included in the study whose samples like pus, pus swabs, sequestrum of bone, and synovial fluid, collected under aseptic precautions, was included and processed for culture and sensitivity.

Exclusion criteria: Patients with malignant and benign tumours, cysts, non infected, non unions, old trauma and osteomyelitis patients on antibiotic therapy were excluded from the study.

Study Procedure

Sample collection and preliminary identification by biochemical tests: All clinical specimens, sequestrum/excised tissue/pus samples received from orthopaedic outpatient and inpatient department were collected in a sterile container. Then the preliminary identification was done by standard procedures (Gram staining and biochemical tests). The culture isolates were identified by gram stain morphology, colony characters and biochemical reactions (28).

Antimicrobial susceptibility test: Antibiotic susceptibility pattern was done on Mueller Hinton Agar by Kirby-Bauer disc diffusion method as recommended by Clinical and Laboratory Standards Institute (CLSI) guidelines. The plates were then incubated at 37°C for 18-24 hours. The zones of complete growth of inhibition around each of the disc were measured by using a scale. The interpretation of zone size into sensitive, intermediate or resistance was based on the standard zone size interpretant chart as per CLSI guidelines (2020) (29). The control strains used were E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.

Statistical Analysis

The data was entered in Microsoft excel and results were expressed in terms of frequency and percentage.

Results

In the present study, out of 100 samples, there were 76% cases reported for the culture positive and culture negative cases 24%. Tibia was the most common bone involved in osteomyelitis (49%) and commonest predisposing factor was seen in trauma 48 (48%) cases, followed by postoperative infections 20 (20%), orthopaedic implants 18 (18%), implant/diabetes mellitus 8 (8%) and least for trauma/diabetes mellitus 2 (2%) (Table/Fig 1),(Table/Fig 2). Out of 100 samples, male were 72% and females were 28%. Staphylococcal spp. (47.4%) was predominant, E. coli (14.4%) and Klebsiella spp. (11.8%), Pseudomonas spp. (9.2%), Proteus spp. (5.2%), CoNS (4%) (Table/Fig 3). Out of 34 organisms isolated, most effective drug of Gram-negative bacilli was colistin, followed by polymyxin B 100 (%), tigycyclin, meropenem, imipenem, and piperacillin/tazobactum (Table/Fig 4). Among the MDR Gram-negative bacilli were ESBL (50%), AmpC (17.6) and MBL (14.7%) and they were 100% sensitive for polymixin B and colistin (Table/Fig 5),(Table/Fig 6),(Table/Fig 7). Out of 42 organisms isolated, most effective drug of Gram-positive Cocci (GPC) was vancomycin, teicoplanin, followed by gentamicin, amikacin, erythromycin, clindamycin and ciprofloxacin (Table/Fig 8).

The MRSA was found to be 44.4%. All the MDR Staphylococcal isolates were 100% sensitive for linezolid (Table/Fig 9).

Discussion

Osteomyelitis is an inflammatory process that affects the bone due to the contiguous infection, direct inoculation, or haematogenous spread of microorganisms (1). It is an infectious disease that is difficult to diagnose, and treatment is complex because of its heterogeneity, pathophysiology, clinical presentation and management.

In the present study, an attempt was made to know the microbiological profile of osteomyelitis and their antibiotic sensitivity pattern. The results for culture positive was observed to be 76% and 24% were culture negative. This study was parallel to the study performed by the other authors where the culture positive results was found to be 86% and 89%, whereas culture negative was observed to be 14% and 11%, respectively (30),(31). There was the another study performed by Shah RV and Sanghavi RV, and Khatoon R et al., results of their study were also in correlation to the present study where the culture positive reported was 64% and 84% and the culture negative observed was 36% and 16% [32,](33). In the study by Padmini B and Deepa S, reported the rate of culture positive to be 87% and the culture negative was observed to be 13% (34). Several predisposing factors associated with osteomyelitis in the present study is comparable with the studies done by various studies (Table/Fig 10) (30),(31),(32),(33),(35).

In the present study, the commonest bone affected in osteomyelitis was Tibia, followed by femur, which was in accordance with the studies done by other workers (Table/Fig 11) (30),(33),(35).

In the present study, total of 76 organisms were isolated. The predominant organisms isolated were S. aureus followed by E. coli, which was in accordance with other studies (Table/Fig 12) (30),(31),(32),(33),(35).

Antibiotic sensitivity was carried out for 100 isolates by Kirby-Bauer disc diffusion method. Of 42 Gram-positive isolates, were 100% sensitive to vancomycin to linezolid and teicoplanin. Among 34 Gram-negative isolates were 100% sensitive to meropenem, imipenem and polymixin B and colistin. Similar sensitivity was reported by Khatoon R et al., (33). AST pattern of GPC and Gram-negative bacilli (GNB) of present study and other studies is shown in (Table/Fig 13) (30),(32),(33).

In the present study, it was observed that the rate of MRSA was found to be (44.4%), ESBL (50%), AmpC (17.6%) and MBL (14.5%). This study was in support with the study performed by Khatoon R et al., where the rate of MRSA was (43.1%), ESBL (51.6%) and AmpC (24.2%) and MBL(14.5%) (33). In the current study, MRSA isolated was observed to be 16 (44.4%) which was in accordance with the study by Khatoon R et al., (33). There were another study also performed by the other author where the rate of MRSA isolated was observed to be 52% and the study by Padmini B and Deepa S, also supported present study where the rate of MRSA was observed to be 66% (31),(34). There was a study by Suguneswari G et al., which was in contrast with the current study where the MRSA isolates was observed to be 23% (35).

Clinical symptoms of osteomyelitis can be non specific and difficult to recognise. Signs and symptoms change depending on the category of infection, organism and anatomical location of the disease. From the present study, it was quite clear that drug resistance bacteria along with MRSA strains are becoming alarming because of their increased resistance towards antibiotics-like amikacin, netilmycin, and to a lesser extent to vancomycin and linezolid that leaves the clinicians with less choice to use the appropriate drug for treatment of chronic osteomyelitis. It is high time to emphasise on surveillance to monitor change in aetiology and to follow one health policy to impede the menace created by MDR bacteria.

Limitation(s)

The drawback of the present research study was the small sample size. More insights about the microbiological profile of osteomyelitis and its antibiotic resistance pattern would have been generated by a large sample size. Also, the present work was self-supported so there was a lack of financial help because of which the gene responsible for MDR could not be targeted.

Conclusion

Isolation of causative organism and performance of antibiotic sensitivity studies are critical in the selection of antimicrobial agents. Therefore, antibiotic therapy should be guided carefully by culture and sensitivity is an effective treatment modality. This will prevent development of drug resistance and indiscriminate use of antibiotics.

References

1.
Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369-79. [crossref][PubMed]
2.
Romanò CL, Romanò D, Logoluso N, Drago L. Bone and joint infections in adults: A comprehensive classification proposal. Eur Orthop Traumatol. 2011;1(6):207-17. [crossref][PubMed]
3.
Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336:999-1007. PMID: 9077380. [crossref][PubMed]
4.
Souza Jorge L, Gomes Chueire A, Baptista Rossit AR. Osteomyelitis: Current challenge. Braz J Infect Dis. 2010;14(3):310. PMID: 20835519. [crossref][PubMed]
5.
Conterno LO, Turchi MD. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2013;9:CD004439. Doi: 10.1002/14651858. CD004439. [crossref]
6.
Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: Current concepts. Infect Dis Clin N Am. 2006;20:789-825. [crossref][PubMed]
7.
Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician. 2011;84(9):1027-33. PMID: 22046943.
8.
Kindsfater K, Jonassen EA. Osteomyelitis in grade II and III open tibia fractures with late debridement. J Orthop Trauma. 1995;9(2):121-27. PMID: 7776031. [crossref][PubMed]
9.
De Boeck H. Osteomyelitis and septic arthritis in children. Acta Ortho Belg. 2005;71(5):505-15.
10.
Maraga NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoaricular infection in children. J Paed Orthop. 2002;22(4):506-10. [crossref]
11.
Mader JT, Calhoun J. Genral Concept of Osteomyelitis. In: Principal and Practice of Infectious Diseases, (Eds.). 6th Edn Elsevier, Churchill Livingstone, Philadelphia. 2005; pp:1182-1196.
12.
Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970;282(4):198- 206. [crossref][PubMed]
13.
Cierny G, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003;414:07-24. [crossref][PubMed]
14.
Calhoun JH, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Seminplast Surg. 2009;23:59-72. [crossref][PubMed]
15.
Chihara S, Segreti J. Osteomyelitis. Dis Mon. 2010;56(1):05-31. [crossref][PubMed]
16.
Sia IG, Berbari EF. Infection and musculoskeletal conditions: Osteomyelitis: Best Pract Res Clin Rheumatol. 2006;20(6):1065-81. [crossref][PubMed]
17.
Dagan R. Management of acute hematogenous osteomyelitis and septic arthritis in the pediatric patient. Pediatr Infect Dis J. 1993;12(1):88-92. [crossref][PubMed]
18.
Zuluaga AF, Galvis W, Saldarriaga JG, Agudelo M, Salazar BE, Vesga O. Etiologic diagnosis of chronic osteomyelitis. Arch Intern Med. 2006;166(1):95-100. [crossref][PubMed]
19.
Berbari EF, Steckelberg JM, Osmon DR. Osteomyelitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingston 2010. 1457-68. [crossref]
20.
Abid AS, Ehan AH, Yonis AR. Epidemiological and bacteriological study of chronic osteomyelitis. Tikrit Medical Journal. 2008;14(1):59-62.
21.
Mandell GL, Bennett JE, Raphael D. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone. 2010;1:1322-30.
22.
Canale ST, James HB. Campbell’s Operative Orthopaedics, 11 th ed. vol. 1. Mosby: St Louis Missouri; 2008. Pp. 695-709.
23.
Rudresh SM, Nagarathnamma T. Extended spectrum β-lactamase producing Enterobacteriaceae & antibiotic coresistance. Indian J Med Res. 2011;133:116-18.
24.
Hodiwala A, Dhoke R, Urhekar AD. Incidence of metallo-betalactamase producing Pseudomonas, Acinetobacter & Enterobacterial isolates in hospitalised patients. Int J Pharmacy Biol Sci. 2013;3:79-83.
25.
Chakraborty D, Basu S, Das S. A study on infections caused by metallo beta lactamase producing Gram negative bacteria in intensive care unit patient AJ Infect Dis. 2010;6:34-39. [crossref]
26.
Khadri H, Alzohairy M. Prevalence and antibiotic susceptibility pattern of methicillin-resistant and coagulase-negative Staphylococci in a tertiary care hospital in India. Int J Med Med Sci. 2010;2(4):116-20.
27.
Khonglah TG, Borgohain B, Khongwir, Ahmed KA. Extremity chronic osteomyelitis in a population of North East India: Epidemiology, clinical characteristics and management. International Journal of Research in Orthopaedics. 2020;4(6):06-23. [crossref]
28.
Collee JG, Fraser AG, Marmion BP, Simmons A. Mackie & Mccartney, Practical Medical Microbiology, Churchill Livingstone, 2006; 14th edition: 135- 141,152,255,796-798.
29.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seven Informational Supplement; CLSI Document M02-A12 and M07-A10, CLSI. 2020.
30.
Wadekar MD, Anuradha K, Venkatesha D. Chronic osteomyelitis: Aetiology and antibiotic susceptibility pattern. International Journal of Recent Trends in Science and Technology. 2014;9(3):337-40.
31.
Singh A, Biswas PP, Sen A. Bacteriological profile of osteomyelitis cases with special reference to antibiotic susceptibility pattern of isolates in a tertiary care hospital of eastern India. J Evolution Med Dent Sci. 2016;5(53):3496-501. Doi: 10.14260/jemds/2016/807. [crossref]
32.
Shah RV, Sanghavi RV. Bacteriological profile in chronic osteomyelitis. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2017;16(10):47-50.
33.
Khatoon R, Khan SA, Jahan N. Antibiotic resistance pattern among aerobic bacterial isolates from osteomyelitis cases attending a Tertiary care hospital of North India with special reference to ESBL, AmpC, MBL and MRSA production. Int J Res Med Sci. 2017;5:482-90. [crossref]
34.
Padmini B, Deepa S. Microbiological profile of chronic osteomyelitis in a tertiary care hospital. Int J Curr Microbiol App Sci. 2021;10(05):826-34. [crossref]
35.
Suguneswari G, Heraman Singh A, Basu R. Bacteriological profile of osteomyelitis in a tertiary care hospital at Visakhapatnam, Andhra Pradesh. Int J Cur Res Rev. 2013;05(20):52-58.

DOI and Others

DOI: 10.7860/JCDR/2023/62082.17785

Date of Submission: Dec 06, 2022
Date of Peer Review: Jan 06, 2023
Date of Acceptance: Feb 27, 2023
Date of Publishing: Apr 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Dec 07, 2022
• Manual Googling: Jan 12, 2023
• iThenticate Software: Feb 21, 2023 (20%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com